Knowledge Hub

Global Report provides an overview of the Graft Versus Host Disease (GVHD) - Epidemiology Insights-2023

Press Release   •   Feb 23, 2017 05:06 EST

DelveInsights Graft versus Host Disease (GVHD) - Market Insights, Epidemiology and Market Forecast-2023-Global report provides an overview of the disease and global historical and forecasted epidemiological data for the diagnosed incident cases of Hematopoietic stem cell transplantations (HSCTs) and Graft Versus Host Disease (GVHD) based upon the sub-types of GVHD along with the type of donor involved in the HSCTs, for

the forecast period (2013-2023) in the 7MM.

View Report @ http://www.marketresearchreports.biz/analysis/938617

GVHD is one of the severe complications associated with Hematopoietic stem cell transplantations (HSCTs). DelveInsight forecasts predict an on-going increase in HSCTs in the near future which shall lead to subsequent increase in the patient population of GVHD. According to DelveInsights estimates, the total number of diagnosed incident cases of Hematopoietic Stem Cell Transplants (HSCTs) shall increase at a Compound Annual Growth Rate (CAGR) of 2.80% from 2013-2023.

The incident rate of GVHD in unrelated donor (URD) is much higher in comparison to the sibling donors (SD), irrespective of the sub-types i.e., acute GVHD (aGVHD) or chronic GVHD (cGVHD). As per DelveInsight forecasts, the global diagnosed incidence cases of aGVHD in sibling donors and aGVHD in unrelated donors, shall increase at a CAGR of 2.63% and 2.51%, respectively, from 2013-2023. In case of cGVHD, the number of diagnosed incident population cGVHD in sibling donors and cGVHD in unrelated donors for the 7MM is expected to accentuate at a CAGR of 1.96% and 1.57%, respectively, by the end of the year 2023.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Get Sample Copy Of This Report @

http://www.marketresearchreports.biz/sample/sample/938617

Scope

- Report covers the disease overview including pathophysiology, symptoms, diagnosis and disease management.

- It focuses on the risk factors and the historical trends of the diagnosed incident cases of allogeneic Hematopoietic Stem Cell Transplants (HSCTs) (which also includes the cases of first transplants along with the total transplants) in the 7MM.

- The Report also covers the detailed historical and forecasted number of diagnosed incident cases of acute GVHD and chronic GVHD, segmented by the type of donors (Sibling donors and unrelated donors) for the 7MM i.e., U.S., EU5 countries(Germany, France, Italy, Spain and United Kingdom) and Japan from 2013-2023.

Follow us on LinkedIn: https://www.linkedin.com/company/marketresearchreports-biz

Table of Contents

Graft Versus Host Disease (GVHD)

Disease Definition

Disease Types

Acute GvHD

Chronic GvHD

Grades of GvHD

Pathophysiology

Risk Factors for GVHD

Diagnosis

Epidemiology and Patient Population

Key Points

Global

Total Diagnosed Incident Cases of Hematopoietic Stem Cell Transplantations (HSCTs) (2013-2023)

Total Diagnosed Incident Cases of aGVHD in Diagnosed Incident Cases of First Allogeneic HSCTs (2013-2023)

Total Diagnosed Incident Cases of cGVHD in Diagnosed Incident Cases of First Allogeneic HSCTs (2013-2023)

United States

Diagnosed Incident Cases of Hematopoietic Stem Cell Transplantations (HSCTs) in United States (2013-2023)

Diagnosed Incident Cases of aGVHD in Diagnosed Incident Cases of First Allogeneic HSCTs in United States (2013-2023)

Diagnosed Incident Cases of cGVHD in Diagnosed Incident Cases of First Allogeneic HSCTs in United States (2013-2023)

Europe

Germany

Diagnosed Incident Cases of Hematopoietic Stem Cell Transplantations (HSCTs) in Germany (2013-2023)

Diagnosed Incident Cases of aGVHD in Diagnosed Incident Cases of First Allogeneic HSCTs in Germany (2013-2023)

Diagnosed Incident Cases of cGVHD in Diagnosed Incident Cases of First Allogeneic HSCTs in Germany (2013-2023)

France

Diagnosed Incident Cases of Hematopoietic Stem Cell Transplantations (HSCTs) in France (2013-2023)

Diagnosed Incident Cases of aGVHD in Diagnosed Incident Cases of First Allogeneic HSCTs in France (2013-2023)

Diagnosed Incident Cases of cGVHD in Diagnosed Incident Cases of First Allogeneic HSCTs in France (2013-2023)

Spain

Diagnosed Incident Cases of Hematopoietic Stem Cell Transplantations (HSCTs) in Spain (2013-2023)

Diagnosed Incident Cases of aGVHD in Diagnosed Incident Cases of First Allogeneic HSCTs in Spain (2013-2023)

Diagnosed Incident Cases of cGVHD in Diagnosed Incident Cases of First Allogeneic HSCTs in Spain (2013-2023)

Italy

Diagnosed Incident Cases of Hematopoietic Stem Cell Transplantations (HSCTs) in Italy (2013-2023)

Diagnosed Incident Cases of aGVHD in Diagnosed Incident Cases of First Allogeneic HSCTs in Italy (2013-2023)

Diagnosed Incident Cases of cGVHD in Diagnosed Incident Cases of First Allogeneic HSCTs in Italy (2013-2023)

United Kingdom

Diagnosed Incident Cases of Hematopoietic Stem Cell Transplantations (HSCTs) in United Kingdom (2013-2023)

Diagnosed Incident Cases of aGVHD in Diagnosed Incident Cases of First Allogeneic HSCTs in United Kingdom (2013-2023)

 

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.